The new Internet Library from the European Patients' Academy will come online towards the end of 2015
The new Internet Library from the European Patients’ Academy (EUPATI) will come online towards the end of 2015, and will be available in seven European languages (English, French, Spanish, Italian, German, Polish and Russian), project director Jan Geissler revealed at last week’s workshop held in Warsaw, Poland, and organized by EUPATI.
According to a EUPATI statement issued after the workshop, “The lynchpin of the plan to engage hundreds of thousands of Europeans will be EUPATI's new Internet Library.” This Library will aim to reach 100,000 patients and consumers with low to middling health literacy levels, and they will be able to access information on themes like side effects and the specific aspects of the medicine development process.
EUPATI is a 12-country, seven-language project with a budget of 10.2 million euros that is due to run until 2017. For patient advocates and advocacy leaders from patient organizations, it aims to provide a so-called Toolbox that will include educational material for teaching others, print material and slide shows for presentations, an internet-based e-Learning course as well as webinars and videos. The plan is for 12,000 patient representatives to use the toolbox by January 2017.
EUPATI represents an effort to empower patients in medicines research and development, and to help them become an integral part of the process. In addition, it seeks to inform the wider public on issues of interest in the same fields, to introduce them to areas like clinical trials and how they can take a more active role in their healthcare, whether it be about medicine safety or the pricing mechanisms that make drugs accessible.
The Warsaw event was funded by the Innovative Medicines Initiative, a partnership of the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Read the full release here.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.